Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy

Documenti analoghi

• Reply to: Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy
  di: Andrea Quattrone, et al.
  Pubblicazione: (2025)
• Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank
  di: Charlie Weige Zhao, et al.
  Pubblicazione: (2026)
• FDA Boosts the Progressive Supranuclear Palsy Rating Scale!
  di: Cristina Sampaio
  Pubblicazione: (2024)
• Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear Palsy
  di: Abigail Amrami, et al.
  Pubblicazione: (2024)
• Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia
  di: Adeline Su Lyn Ng, et al.
  Pubblicazione: (2024)